NCT06266091 2025-07-20Treat Malignant Ascites Caused by Gastrointestinal or Ovarian Cancer With M701 Bispecific AntibodyWuhan YZY Biopharma Co., Ltd.Phase 2 Completed115 enrolled
NCT06433869 2024-05-30The Efficacy of Bevacizumab and Serplulimab Combined With Recombinant Mutant HumanTumor Necrosis Factor(rmhTNF-NC) in the Treatment of Malignant AscitesSun Yat-sen UniversityPhase 2 Recruiting60 enrolled